Group 2354.png

Guidelines and risk classification

LDL-C lowering is an integral part of 2025 Focused Update of the 2019 ESC/EAS recommendations for ASCVD and secondary prevention.1

Treatment goals for low-density lipoprotein cholesterol across categories of total cardiovascular risk1

image 21.png

EDA Approval No: WF0424OA5708/042026 EDA Invalidation Date:06/04/2027

References

  1. Mach F, Koskinas KC, Roeters van Lennep JE, Tokgözoğlu L, Badimon L, Baigent C, Benn M, Binder CJ, Catapano AL, De Backer GG, Delgado V. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Heart Journal. 2025 Aug 29:ehaf190.. Available at: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf190/8234482 . Last accessed:16/09/2025.

Adverse Events Reporting

We encourage using the following Electronic reporting tool for reporting into the safety database directly:
If the electronic reporting tool is not working - please use the following: https://www.report.novartis.com
1 - Generic Mailbox: [email protected]
2 - CISCO: +20 2 2 2861000: Press 3 for Adverse Events Reporting